Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient This investigator-initiated, ...
Leveraging Artificial Intelligence to Uncover Symptom Burden in Palliative Care: Analysis of Nonscheduled Visits Using a Phi-3 Small Language Model This was a single-center, phase III, prospective ...
MONTPELLIER, France--(BUSINESS WIRE)--Teva presented at ECNP 2024 * new positive efficacy, safety, and tolerability results for Phase 3 SOLARIS trial evaluating Olanzapine LAI (TV-‘749 / mdc-TJK) in ...
Olanzapine LAI (TEV-'749) is an investigational once-monthly subcutaneous LAI of the second-generation antipsychotic olanzapine and is not approved by any regulatory authority for any use, and its ...
Overall, the weighted estimates indicated 35,860,972 (SE = 2,610,036) nonfederal ambulatory healthcare visits in the United States that included a prescription for an antipsychotic during the survey ...
MONTPELLIER, France--(BUSINESS WIRE)--Medincell (Paris:MEDCL): ACCESS HERE THE FULL PRESS RELEASE David Heuzé Head of Corporate and Financial Communications, and ESG [email protected] / +33 (0 ...
The population-based cohort study included electronic health record data from the Hong Kong Hospital Authority for more than 11,051 adults with schizophrenia. Participants had used clozapine (n = 1450 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback